NOVEL QUINOXALINE DERIVATIVES

WIPO Patent Application WO/2011/122815

A3

This invention relates to a novel compound represented by the following Chemical Formula 1, a process for preparing it, and its pharmaceutically approved salt comprising it as an active ingredient. The compound of this invention is GLP 1 receptor regulating low molecular weight compound useful for treatment of metabolic diseases such as diabetes and obesity by regulating the function of glucagon like peptide 1 receptor (GLP 1 receptor) for the disease or disorder carried by GLP 1 since it has the effects on a drop of blood sugar and an improvement of insulin resistance.

MOON HO-SANG (KR)
YANG JAE-SUNG (KR)
KIM MI-KYUNG (KR)
KIM JIN-KWAN (KR)
LEE JAE-YOUNG (KR)
KANG SO-MI (KR)
KIM HA-DONG (KR)
SHIN CHANG-YELL (KR)
CHEONG YE-HWANG (KR)
YANG EUN-KYOUNG (KR)
CHOI SONG-HYEN (KR)
PARK YOUNG-SOO (KR)
KIM EUN-JUNG (KR)
CHAE YU-NA (KR)
CHO EUN-JUNG (KR)
SON MOON-HO (KR)
KIM SOON-HOE (KR)

PCT/KR2011/002115

March 08, 2012

March 28, 2011

Click for automatic bibliography generation  

DONG A PHARM CO LTD (KR)
MOON HO-SANG (KR)
YANG JAE-SUNG (KR)
KIM MI-KYUNG (KR)
KIM JIN-KWAN (KR)
LEE JAE-YOUNG (KR)
KANG SO-MI (KR)
KIM HA-DONG (KR)
SHIN CHANG-YELL (KR)
CHEONG YE-HWANG (KR)
YANG EUN-KYOUNG (KR)
CHOI SONG-HYEN (KR)
PARK YOUNG-SOO (KR)
KIM EUN-JUNG (KR)
CHAE YU-NA (KR)
CHO EUN-JUNG (KR)
SON MOON-HO (KR)
KIM SOON-HOE (KR)

C07D417/14; A61K31/498; A61P3/04; A61P3/10; C07D403/12

US3997535A	1976-12-14
US20060142294A1	2006-06-29
US20040116437A1	2004-06-17

ROH, Jae-Chull (4F.,Halla Building, 641-17,Yeoksam-dong, Gangnam-gu, Seoul 135-909, KR)

View/Download PDF      PDF Help

Previous Patent: ELECTROCHEMICAL CELL HAVING A GAS-PERMEABLE MEMBRANE

Next Patent: TECHNIQUES FOR MANAGING DEVICES NOT DIRECTLY ACCESSIBLE TO DEVICE MANAGEMENT SERVER